Skip to content

The Gravity-VAP (Ventilator-Associated Pneumonia) Trial

Prospective, Randomized, Multi-Center Trial of Lateral Trendelenburg Versus Semi-Recumbent Body Position in Mechanically Ventilated Patients For The Prevention of Ventilator-Associated Pneumonia

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01138540
Acronym
Gravity-VAP
Enrollment
800
Registered
2010-06-07
Start date
2010-11-30
Completion date
2015-04-30
Last updated
2017-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator Associated Pneumonia

Keywords

VAP

Brief summary

This study is planned to compare, in patients sedated, intubated and mechanically ventilated, the efficacy and safety of the Lateral Trendelenburg position in comparison to the Semirecumbent Position to prevent incidence of ventilator-associated pneumonia (VAP).

Detailed description

This study is planned to compare, in patients sedated, intubated or tracheostomized and mechanically ventilated, the efficacy and safety of two body positions in reducing incidence of ventilator-associated pneumonia. The semi-recumbent position prevents gastro-oropharyngeal aspiration of bacteria laden gastric contents and the gastro-pulmonary route of colonization. The lateral-Trendelenburg position aims to promote outward drainage of bacteria-laden oropharyngeal secretion, while avoiding bacterial translocation from the oropharynx into the lungs.

Interventions

OTHERlateral-Trendelenburg position

lateral-Trendelenburg position of patients laying in the bed of the ICU, keeping trachea and tracheal tube horizontal, compared to the standard treatment (semirecumbent position) for the prevention of VAP

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Azienda Ospedaliera San Gerardo di Monza
CollaboratorOTHER
Ospedale Nuovo del Mugello
CollaboratorUNKNOWN
Ospedale San Donato
CollaboratorOTHER
Azienda USL Reggio Emilia - IRCCS
CollaboratorOTHER_GOV
Ospedale S. Giovanni Bosco
CollaboratorOTHER
Fondazione IRCCS Policlinico San Matteo di Pavia
CollaboratorOTHER
Azienda Ospedaliero-Universitaria di Modena
CollaboratorOTHER
Ospedale Città di Sesto San Giovanni
CollaboratorUNKNOWN
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CollaboratorOTHER
Azienda Ospedaliero-Universitaria di Parma
CollaboratorOTHER
Goethe University
CollaboratorOTHER
Clinical Hospital Centre Zagreb
CollaboratorOTHER
Santa Chiara Hospital
CollaboratorOTHER
Hospital Clinic of Barcelona
CollaboratorOTHER
Policlinico Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years 2. Patients expected to be oro-tracheally intubated for at least 48 hours or longer 3. Enrollment time window within 12 hours following intubation

Exclusion criteria

1. Current and past participation in an other intervention trial conflicting with the present study 2. Previous endotracheal intubation longer than 12 hours during the previous 30 days 3. Patients with documented bronchiectasis 4. Cystic fibrosis 5. Witnessed pulmonary aspiration either prior or at intubation 6. Patients with increased intracranial pressure, brain edema; or medical conditions that can worsen with increase in intracranial pressure 7. Patients with significant heart failure and activity impairment (Class III-IV of the New York Heart Association (NYHA) 8. Spinal cord injury 9. BMI \> 35, or weight above 300 pound 10. Grade IV Intra-abdominal pressure: IAP \> 25 mmHg or abdominal compartment syndrome , defined as a sustained IAP \> 20 mmHg that is associated with new organ dysfunction / failure 11. Pregnancy 12. Orthopedic problems that will not allow the patient to be kept in one of the study positions

Design outcomes

Primary

MeasureTime frameDescription
Incidence of ventilator-associated pneumonia14 days of mechanical ventilationincidence of ventilator-associated pneumonia within the first 14 days of intubation, confirmed by quantitative microbiology analysis of either bronchoalveolar lavage (BAL) or mini-BAL fluids or secretions collected through protected specimen brush (PSB)

Secondary

MeasureTime frame
Duration of intensive care unit staydays
Duration of hospital staydays
Safety of the Semi-Recumbent and Lateral-Trendelenburg position14 days
Use of Sedatives14 days
Duration of mechanical ventilation14 days
ICU mortality28 days
Hospital mortality28 days
28 Days mortality28 days
Assessment of nursing-related issues in the lateral-Trendelenburg position14 days
Use of Antimicrobials14 days

Countries

Italy, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026